DANIEL
GARCÍA RINCÓN
Investigador fins a 2019
Instituto Ramón y Cajal de Investigación Sanitaria
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Instituto Ramón y Cajal de Investigación Sanitaria (5)
2020
-
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure
Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886
2019
-
Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia
Frontiers in Pharmacology, Vol. 9, Núm. JAN
-
Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
Translational Neurodegeneration, Vol. 8, Núm. 1
2015
-
Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons
Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 44, pp. 13693-13698
-
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
Cell Death and Differentiation, Vol. 22, Núm. 10, pp. 1618-1629